nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.501	1	CpDpCtD
Memantine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0526	0.211	CbGbCtD
Memantine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0341	0.137	CbGbCtD
Memantine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0277	0.111	CbGbCtD
Memantine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0236	0.0944	CbGbCtD
Memantine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0236	0.0944	CbGbCtD
Memantine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0222	0.0888	CbGbCtD
Memantine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0218	0.0872	CbGbCtD
Memantine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.021	0.0842	CbGbCtD
Memantine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0121	0.0484	CbGbCtD
Memantine—CYP2C19—Losartan—type 2 diabetes mellitus	0.011	0.0442	CbGbCtD
Memantine—GRIN2B—nerve—type 2 diabetes mellitus	0.00161	0.213	CbGeAlD
Memantine—GRIN2A—nerve—type 2 diabetes mellitus	0.00141	0.186	CbGeAlD
Memantine—HTR3A—nerve—type 2 diabetes mellitus	0.000934	0.123	CbGeAlD
Memantine—DRD2—nerve—type 2 diabetes mellitus	0.000572	0.0754	CbGeAlD
Memantine—HTR3A—islet of Langerhans—type 2 diabetes mellitus	0.000453	0.0597	CbGeAlD
Memantine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000423	0.0558	CbGeAlD
Memantine—SLC22A2—kidney—type 2 diabetes mellitus	0.000372	0.049	CbGeAlD
Memantine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000362	0.0477	CbGeAlD
Memantine—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000284	0.0374	CbGeAlD
Memantine—DRD2—retina—type 2 diabetes mellitus	0.000237	0.0312	CbGeAlD
Memantine—CYP2A6—liver—type 2 diabetes mellitus	0.000199	0.0262	CbGeAlD
Memantine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.00018	0.0238	CbGeAlD
Memantine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000162	0.0214	CbGeAlD
Memantine—CYP2B6—kidney—type 2 diabetes mellitus	0.000158	0.0209	CbGeAlD
Memantine—CYP2C19—liver—type 2 diabetes mellitus	0.000128	0.0169	CbGeAlD
Memantine—CYP2B6—liver—type 2 diabetes mellitus	0.0001	0.0132	CbGeAlD
Memantine—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.26e-05	0.000237	CcSEcCtD
Memantine—Shock—Metformin—type 2 diabetes mellitus	4.26e-05	0.000237	CcSEcCtD
Memantine—Insomnia—Orlistat—type 2 diabetes mellitus	4.25e-05	0.000237	CcSEcCtD
Memantine—Malaise—Losartan—type 2 diabetes mellitus	4.25e-05	0.000237	CcSEcCtD
Memantine—Anxiety—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000237	CcSEcCtD
Memantine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.25e-05	0.000237	CcSEcCtD
Memantine—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.25e-05	0.000237	CcSEcCtD
Memantine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.24e-05	0.000236	CcSEcCtD
Memantine—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.24e-05	0.000236	CcSEcCtD
Memantine—Vertigo—Losartan—type 2 diabetes mellitus	4.23e-05	0.000236	CcSEcCtD
Memantine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.23e-05	0.000236	CcSEcCtD
Memantine—Somnolence—Valsartan—type 2 diabetes mellitus	4.23e-05	0.000236	CcSEcCtD
Memantine—Syncope—Losartan—type 2 diabetes mellitus	4.22e-05	0.000235	CcSEcCtD
Memantine—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.22e-05	0.000235	CcSEcCtD
Memantine—Leukopenia—Losartan—type 2 diabetes mellitus	4.22e-05	0.000235	CcSEcCtD
Memantine—Discomfort—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000235	CcSEcCtD
Memantine—Skin disorder—Metformin—type 2 diabetes mellitus	4.2e-05	0.000234	CcSEcCtD
Memantine—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000234	CcSEcCtD
Memantine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.18e-05	0.000233	CcSEcCtD
Memantine—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.18e-05	0.000233	CcSEcCtD
Memantine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000233	CcSEcCtD
Memantine—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.17e-05	0.000232	CcSEcCtD
Memantine—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.17e-05	0.000232	CcSEcCtD
Memantine—Palpitations—Losartan—type 2 diabetes mellitus	4.16e-05	0.000232	CcSEcCtD
Memantine—Nausea—Glimepiride—type 2 diabetes mellitus	4.15e-05	0.000231	CcSEcCtD
Memantine—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000231	CcSEcCtD
Memantine—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.14e-05	0.000231	CcSEcCtD
Memantine—Nausea—Sitagliptin—type 2 diabetes mellitus	4.14e-05	0.000231	CcSEcCtD
Memantine—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.13e-05	0.00023	CcSEcCtD
Memantine—Asthenia—Glyburide—type 2 diabetes mellitus	4.13e-05	0.00023	CcSEcCtD
Memantine—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.13e-05	0.00023	CcSEcCtD
Memantine—Anorexia—Metformin—type 2 diabetes mellitus	4.13e-05	0.00023	CcSEcCtD
Memantine—Cough—Losartan—type 2 diabetes mellitus	4.11e-05	0.000229	CcSEcCtD
Memantine—Urticaria—Gliclazide—type 2 diabetes mellitus	4.11e-05	0.000229	CcSEcCtD
Memantine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.1e-05	0.000229	CcSEcCtD
Memantine—Alopecia—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000229	CcSEcCtD
Memantine—Fatigue—Valsartan—type 2 diabetes mellitus	4.1e-05	0.000228	CcSEcCtD
Memantine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.09e-05	0.000228	CcSEcCtD
Memantine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.09e-05	0.000228	CcSEcCtD
Memantine—Oedema—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.000228	CcSEcCtD
Memantine—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.08e-05	0.000228	CcSEcCtD
Memantine—Pruritus—Glyburide—type 2 diabetes mellitus	4.08e-05	0.000227	CcSEcCtD
Memantine—Mental disorder—Ramipril—type 2 diabetes mellitus	4.06e-05	0.000227	CcSEcCtD
Memantine—Constipation—Valsartan—type 2 diabetes mellitus	4.06e-05	0.000227	CcSEcCtD
Memantine—Infection—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.000226	CcSEcCtD
Memantine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.06e-05	0.000226	CcSEcCtD
Memantine—Fatigue—Orlistat—type 2 diabetes mellitus	4.05e-05	0.000226	CcSEcCtD
Memantine—Hypotension—Metformin—type 2 diabetes mellitus	4.04e-05	0.000225	CcSEcCtD
Memantine—Malnutrition—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000225	CcSEcCtD
Memantine—Shock—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000224	CcSEcCtD
Memantine—Pain—Orlistat—type 2 diabetes mellitus	4.02e-05	0.000224	CcSEcCtD
Memantine—Myalgia—Losartan—type 2 diabetes mellitus	4.01e-05	0.000223	CcSEcCtD
Memantine—Chest pain—Losartan—type 2 diabetes mellitus	4.01e-05	0.000223	CcSEcCtD
Memantine—Arthralgia—Losartan—type 2 diabetes mellitus	4.01e-05	0.000223	CcSEcCtD
Memantine—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.01e-05	0.000223	CcSEcCtD
Memantine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000223	CcSEcCtD
Memantine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4e-05	0.000223	CcSEcCtD
Memantine—Anxiety—Losartan—type 2 diabetes mellitus	4e-05	0.000223	CcSEcCtD
Memantine—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000222	CcSEcCtD
Memantine—Rash—Bromocriptine—type 2 diabetes mellitus	3.97e-05	0.000221	CcSEcCtD
Memantine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.97e-05	0.000221	CcSEcCtD
Memantine—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.97e-05	0.000221	CcSEcCtD
Memantine—Tension—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000221	CcSEcCtD
Memantine—Discomfort—Losartan—type 2 diabetes mellitus	3.96e-05	0.000221	CcSEcCtD
Memantine—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.96e-05	0.00022	CcSEcCtD
Memantine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.95e-05	0.00022	CcSEcCtD
Memantine—Headache—Bromocriptine—type 2 diabetes mellitus	3.95e-05	0.00022	CcSEcCtD
Memantine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.94e-05	0.00022	CcSEcCtD
Memantine—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.94e-05	0.00022	CcSEcCtD
Memantine—Nervousness—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000219	CcSEcCtD
Memantine—Dry mouth—Losartan—type 2 diabetes mellitus	3.92e-05	0.000219	CcSEcCtD
Memantine—Anorexia—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000217	CcSEcCtD
Memantine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.89e-05	0.000217	CcSEcCtD
Memantine—Paraesthesia—Metformin—type 2 diabetes mellitus	3.89e-05	0.000217	CcSEcCtD
Memantine—Confusional state—Losartan—type 2 diabetes mellitus	3.88e-05	0.000216	CcSEcCtD
Memantine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.87e-05	0.000216	CcSEcCtD
Memantine—Dyspnoea—Metformin—type 2 diabetes mellitus	3.86e-05	0.000215	CcSEcCtD
Memantine—Somnolence—Metformin—type 2 diabetes mellitus	3.85e-05	0.000214	CcSEcCtD
Memantine—Oedema—Losartan—type 2 diabetes mellitus	3.84e-05	0.000214	CcSEcCtD
Memantine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.84e-05	0.000214	CcSEcCtD
Memantine—Infection—Losartan—type 2 diabetes mellitus	3.82e-05	0.000213	CcSEcCtD
Memantine—Hypotension—Irbesartan—type 2 diabetes mellitus	3.82e-05	0.000213	CcSEcCtD
Memantine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.81e-05	0.000212	CcSEcCtD
Memantine—Dyspepsia—Metformin—type 2 diabetes mellitus	3.81e-05	0.000212	CcSEcCtD
Memantine—Tremor—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000211	CcSEcCtD
Memantine—Shock—Losartan—type 2 diabetes mellitus	3.78e-05	0.000211	CcSEcCtD
Memantine—Urticaria—Valsartan—type 2 diabetes mellitus	3.78e-05	0.00021	CcSEcCtD
Memantine—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.77e-05	0.00021	CcSEcCtD
Memantine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.76e-05	0.00021	CcSEcCtD
Memantine—Decreased appetite—Metformin—type 2 diabetes mellitus	3.76e-05	0.00021	CcSEcCtD
Memantine—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.76e-05	0.000209	CcSEcCtD
Memantine—Tachycardia—Losartan—type 2 diabetes mellitus	3.75e-05	0.000209	CcSEcCtD
Memantine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000209	CcSEcCtD
Memantine—Nausea—Bromocriptine—type 2 diabetes mellitus	3.74e-05	0.000209	CcSEcCtD
Memantine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.74e-05	0.000208	CcSEcCtD
Memantine—Fatigue—Metformin—type 2 diabetes mellitus	3.73e-05	0.000208	CcSEcCtD
Memantine—Urticaria—Orlistat—type 2 diabetes mellitus	3.73e-05	0.000208	CcSEcCtD
Memantine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.72e-05	0.000207	CcSEcCtD
Memantine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.72e-05	0.000207	CcSEcCtD
Memantine—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.71e-05	0.000207	CcSEcCtD
Memantine—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.71e-05	0.000207	CcSEcCtD
Memantine—Asthenia—Gliclazide—type 2 diabetes mellitus	3.71e-05	0.000207	CcSEcCtD
Memantine—Agitation—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000207	CcSEcCtD
Memantine—Constipation—Metformin—type 2 diabetes mellitus	3.7e-05	0.000206	CcSEcCtD
Memantine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.67e-05	0.000204	CcSEcCtD
Memantine—Anorexia—Losartan—type 2 diabetes mellitus	3.66e-05	0.000204	CcSEcCtD
Memantine—Vomiting—Glyburide—type 2 diabetes mellitus	3.66e-05	0.000204	CcSEcCtD
Memantine—Pruritus—Gliclazide—type 2 diabetes mellitus	3.66e-05	0.000204	CcSEcCtD
Memantine—Malaise—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000203	CcSEcCtD
Memantine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000203	CcSEcCtD
Memantine—Rash—Glyburide—type 2 diabetes mellitus	3.63e-05	0.000202	CcSEcCtD
Memantine—Somnolence—Irbesartan—type 2 diabetes mellitus	3.63e-05	0.000202	CcSEcCtD
Memantine—Dermatitis—Glyburide—type 2 diabetes mellitus	3.63e-05	0.000202	CcSEcCtD
Memantine—Vertigo—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000202	CcSEcCtD
Memantine—Syncope—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000202	CcSEcCtD
Memantine—Leukopenia—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000201	CcSEcCtD
Memantine—Headache—Glyburide—type 2 diabetes mellitus	3.61e-05	0.000201	CcSEcCtD
Memantine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.6e-05	0.0002	CcSEcCtD
Memantine—Hypotension—Losartan—type 2 diabetes mellitus	3.59e-05	0.0002	CcSEcCtD
Memantine—Palpitations—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000199	CcSEcCtD
Memantine—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.57e-05	0.000199	CcSEcCtD
Memantine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.000198	CcSEcCtD
Memantine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000198	CcSEcCtD
Memantine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.54e-05	0.000197	CcSEcCtD
Memantine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.54e-05	0.000197	CcSEcCtD
Memantine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000197	CcSEcCtD
Memantine—Cough—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000196	CcSEcCtD
Memantine—Fatigue—Irbesartan—type 2 diabetes mellitus	3.52e-05	0.000196	CcSEcCtD
Memantine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.5e-05	0.000195	CcSEcCtD
Memantine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.5e-05	0.000195	CcSEcCtD
Memantine—Convulsion—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000195	CcSEcCtD
Memantine—Pain—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000195	CcSEcCtD
Memantine—Constipation—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000195	CcSEcCtD
Memantine—Insomnia—Losartan—type 2 diabetes mellitus	3.48e-05	0.000194	CcSEcCtD
Memantine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.46e-05	0.000193	CcSEcCtD
Memantine—Paraesthesia—Losartan—type 2 diabetes mellitus	3.45e-05	0.000192	CcSEcCtD
Memantine—Urticaria—Metformin—type 2 diabetes mellitus	3.44e-05	0.000192	CcSEcCtD
Memantine—Chest pain—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000192	CcSEcCtD
Memantine—Arthralgia—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000192	CcSEcCtD
Memantine—Myalgia—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000192	CcSEcCtD
Memantine—Dyspnoea—Losartan—type 2 diabetes mellitus	3.43e-05	0.000191	CcSEcCtD
Memantine—Anxiety—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000191	CcSEcCtD
Memantine—Nausea—Glyburide—type 2 diabetes mellitus	3.42e-05	0.000191	CcSEcCtD
Memantine—Abdominal pain—Metformin—type 2 diabetes mellitus	3.42e-05	0.000191	CcSEcCtD
Memantine—Dizziness—Gliclazide—type 2 diabetes mellitus	3.42e-05	0.000191	CcSEcCtD
Memantine—Somnolence—Losartan—type 2 diabetes mellitus	3.42e-05	0.00019	CcSEcCtD
Memantine—Asthenia—Valsartan—type 2 diabetes mellitus	3.41e-05	0.00019	CcSEcCtD
Memantine—Discomfort—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000189	CcSEcCtD
Memantine—Dyspepsia—Losartan—type 2 diabetes mellitus	3.38e-05	0.000189	CcSEcCtD
Memantine—Asthenia—Orlistat—type 2 diabetes mellitus	3.37e-05	0.000188	CcSEcCtD
Memantine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000188	CcSEcCtD
Memantine—Pruritus—Valsartan—type 2 diabetes mellitus	3.36e-05	0.000187	CcSEcCtD
Memantine—Dry mouth—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000187	CcSEcCtD
Memantine—Decreased appetite—Losartan—type 2 diabetes mellitus	3.34e-05	0.000186	CcSEcCtD
Memantine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.34e-05	0.000186	CcSEcCtD
Memantine—Confusional state—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000185	CcSEcCtD
Memantine—Pruritus—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000185	CcSEcCtD
Memantine—Fatigue—Losartan—type 2 diabetes mellitus	3.31e-05	0.000185	CcSEcCtD
Memantine—Oedema—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000184	CcSEcCtD
Memantine—Vomiting—Gliclazide—type 2 diabetes mellitus	3.29e-05	0.000183	CcSEcCtD
Memantine—Constipation—Losartan—type 2 diabetes mellitus	3.29e-05	0.000183	CcSEcCtD
Memantine—Pain—Losartan—type 2 diabetes mellitus	3.29e-05	0.000183	CcSEcCtD
Memantine—Rash—Gliclazide—type 2 diabetes mellitus	3.26e-05	0.000182	CcSEcCtD
Memantine—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.26e-05	0.000182	CcSEcCtD
Memantine—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.25e-05	0.000181	CcSEcCtD
Memantine—Urticaria—Irbesartan—type 2 diabetes mellitus	3.25e-05	0.000181	CcSEcCtD
Memantine—Shock—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000181	CcSEcCtD
Memantine—Headache—Gliclazide—type 2 diabetes mellitus	3.24e-05	0.000181	CcSEcCtD
Memantine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.23e-05	0.00018	CcSEcCtD
Memantine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.23e-05	0.00018	CcSEcCtD
Memantine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.23e-05	0.00018	CcSEcCtD
Memantine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.23e-05	0.00018	CcSEcCtD
Memantine—Tachycardia—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000179	CcSEcCtD
Memantine—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.21e-05	0.000179	CcSEcCtD
Memantine—Skin disorder—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000178	CcSEcCtD
Memantine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000178	CcSEcCtD
Memantine—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.17e-05	0.000177	CcSEcCtD
Memantine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.14e-05	0.000175	CcSEcCtD
Memantine—Dizziness—Valsartan—type 2 diabetes mellitus	3.14e-05	0.000175	CcSEcCtD
Memantine—Anorexia—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000175	CcSEcCtD
Memantine—Dizziness—Orlistat—type 2 diabetes mellitus	3.11e-05	0.000173	CcSEcCtD
Memantine—Asthenia—Metformin—type 2 diabetes mellitus	3.11e-05	0.000173	CcSEcCtD
Memantine—Hypotension—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000172	CcSEcCtD
Memantine—Nausea—Gliclazide—type 2 diabetes mellitus	3.07e-05	0.000171	CcSEcCtD
Memantine—Pruritus—Metformin—type 2 diabetes mellitus	3.06e-05	0.000171	CcSEcCtD
Memantine—Urticaria—Losartan—type 2 diabetes mellitus	3.05e-05	0.00017	CcSEcCtD
Memantine—Abdominal pain—Losartan—type 2 diabetes mellitus	3.04e-05	0.000169	CcSEcCtD
Memantine—Body temperature increased—Losartan—type 2 diabetes mellitus	3.04e-05	0.000169	CcSEcCtD
Memantine—Vomiting—Valsartan—type 2 diabetes mellitus	3.02e-05	0.000168	CcSEcCtD
Memantine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.01e-05	0.000168	CcSEcCtD
Memantine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3e-05	0.000167	CcSEcCtD
Memantine—Rash—Valsartan—type 2 diabetes mellitus	3e-05	0.000167	CcSEcCtD
Memantine—Dermatitis—Valsartan—type 2 diabetes mellitus	2.99e-05	0.000167	CcSEcCtD
Memantine—Vomiting—Orlistat—type 2 diabetes mellitus	2.99e-05	0.000166	CcSEcCtD
Memantine—Insomnia—Ramipril—type 2 diabetes mellitus	2.98e-05	0.000166	CcSEcCtD
Memantine—Headache—Valsartan—type 2 diabetes mellitus	2.98e-05	0.000166	CcSEcCtD
Memantine—Diarrhoea—Metformin—type 2 diabetes mellitus	2.96e-05	0.000165	CcSEcCtD
Memantine—Rash—Orlistat—type 2 diabetes mellitus	2.96e-05	0.000165	CcSEcCtD
Memantine—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000165	CcSEcCtD
Memantine—Dermatitis—Orlistat—type 2 diabetes mellitus	2.96e-05	0.000165	CcSEcCtD
Memantine—Headache—Orlistat—type 2 diabetes mellitus	2.94e-05	0.000164	CcSEcCtD
Memantine—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000164	CcSEcCtD
Memantine—Asthenia—Irbesartan—type 2 diabetes mellitus	2.93e-05	0.000163	CcSEcCtD
Memantine—Somnolence—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000163	CcSEcCtD
Memantine—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000162	CcSEcCtD
Memantine—Pruritus—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000161	CcSEcCtD
Memantine—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.87e-05	0.00016	CcSEcCtD
Memantine—Dizziness—Metformin—type 2 diabetes mellitus	2.86e-05	0.00016	CcSEcCtD
Memantine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000159	CcSEcCtD
Memantine—Fatigue—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000158	CcSEcCtD
Memantine—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.83e-05	0.000158	CcSEcCtD
Memantine—Nausea—Valsartan—type 2 diabetes mellitus	2.82e-05	0.000157	CcSEcCtD
Memantine—Constipation—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000157	CcSEcCtD
Memantine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.79e-05	0.000156	CcSEcCtD
Memantine—Nausea—Orlistat—type 2 diabetes mellitus	2.79e-05	0.000155	CcSEcCtD
Memantine—Asthenia—Losartan—type 2 diabetes mellitus	2.76e-05	0.000154	CcSEcCtD
Memantine—Vomiting—Metformin—type 2 diabetes mellitus	2.75e-05	0.000153	CcSEcCtD
Memantine—Rash—Metformin—type 2 diabetes mellitus	2.73e-05	0.000152	CcSEcCtD
Memantine—Dermatitis—Metformin—type 2 diabetes mellitus	2.73e-05	0.000152	CcSEcCtD
Memantine—Pruritus—Losartan—type 2 diabetes mellitus	2.72e-05	0.000152	CcSEcCtD
Memantine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000151	CcSEcCtD
Memantine—Headache—Metformin—type 2 diabetes mellitus	2.71e-05	0.000151	CcSEcCtD
Memantine—Dizziness—Irbesartan—type 2 diabetes mellitus	2.7e-05	0.000151	CcSEcCtD
Memantine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.7e-05	0.00015	CcSEcCtD
Memantine—Diarrhoea—Losartan—type 2 diabetes mellitus	2.63e-05	0.000147	CcSEcCtD
Memantine—Urticaria—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000146	CcSEcCtD
Memantine—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000145	CcSEcCtD
Memantine—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000145	CcSEcCtD
Memantine—Vomiting—Irbesartan—type 2 diabetes mellitus	2.6e-05	0.000145	CcSEcCtD
Memantine—Rash—Irbesartan—type 2 diabetes mellitus	2.58e-05	0.000144	CcSEcCtD
Memantine—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.57e-05	0.000143	CcSEcCtD
Memantine—Nausea—Metformin—type 2 diabetes mellitus	2.57e-05	0.000143	CcSEcCtD
Memantine—Headache—Irbesartan—type 2 diabetes mellitus	2.56e-05	0.000143	CcSEcCtD
Memantine—Dizziness—Losartan—type 2 diabetes mellitus	2.54e-05	0.000142	CcSEcCtD
Memantine—Vomiting—Losartan—type 2 diabetes mellitus	2.44e-05	0.000136	CcSEcCtD
Memantine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.43e-05	0.000135	CcSEcCtD
Memantine—Nausea—Irbesartan—type 2 diabetes mellitus	2.43e-05	0.000135	CcSEcCtD
Memantine—Rash—Losartan—type 2 diabetes mellitus	2.42e-05	0.000135	CcSEcCtD
Memantine—Dermatitis—Losartan—type 2 diabetes mellitus	2.42e-05	0.000135	CcSEcCtD
Memantine—Headache—Losartan—type 2 diabetes mellitus	2.41e-05	0.000134	CcSEcCtD
Memantine—Asthenia—Ramipril—type 2 diabetes mellitus	2.37e-05	0.000132	CcSEcCtD
Memantine—Pruritus—Ramipril—type 2 diabetes mellitus	2.33e-05	0.00013	CcSEcCtD
Memantine—Nausea—Losartan—type 2 diabetes mellitus	2.28e-05	0.000127	CcSEcCtD
Memantine—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.26e-05	0.000126	CcSEcCtD
Memantine—Dizziness—Ramipril—type 2 diabetes mellitus	2.18e-05	0.000121	CcSEcCtD
Memantine—Vomiting—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000117	CcSEcCtD
Memantine—Rash—Ramipril—type 2 diabetes mellitus	2.08e-05	0.000116	CcSEcCtD
Memantine—Dermatitis—Ramipril—type 2 diabetes mellitus	2.08e-05	0.000116	CcSEcCtD
Memantine—Headache—Ramipril—type 2 diabetes mellitus	2.07e-05	0.000115	CcSEcCtD
Memantine—Nausea—Ramipril—type 2 diabetes mellitus	1.96e-05	0.000109	CcSEcCtD
Memantine—CYP2A6—Metabolism—HMGCR—type 2 diabetes mellitus	7.77e-06	0.000124	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	7.67e-06	0.000123	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.62e-06	0.000122	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ADRA2A—type 2 diabetes mellitus	7.6e-06	0.000122	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	7.56e-06	0.000121	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	7.54e-06	0.000121	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	7.54e-06	0.000121	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.52e-06	0.00012	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	7.5e-06	0.00012	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	7.44e-06	0.000119	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CPT1A—type 2 diabetes mellitus	7.37e-06	0.000118	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTR—type 2 diabetes mellitus	7.37e-06	0.000118	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—C3—type 2 diabetes mellitus	7.33e-06	0.000117	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2E1—type 2 diabetes mellitus	7.3e-06	0.000117	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	7.26e-06	0.000116	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	7.24e-06	0.000116	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NAMPT—type 2 diabetes mellitus	7.23e-06	0.000116	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC2A1—type 2 diabetes mellitus	7.22e-06	0.000116	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1A2—type 2 diabetes mellitus	7.22e-06	0.000116	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—LIPC—type 2 diabetes mellitus	7.18e-06	0.000115	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HBA1—type 2 diabetes mellitus	7.18e-06	0.000115	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GCK—type 2 diabetes mellitus	7.18e-06	0.000115	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	7.16e-06	0.000114	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP11A1—type 2 diabetes mellitus	7.14e-06	0.000114	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IAPP—type 2 diabetes mellitus	7.11e-06	0.000114	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	7.08e-06	0.000113	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—INSR—type 2 diabetes mellitus	7.07e-06	0.000113	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.07e-06	0.000113	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP3A4—type 2 diabetes mellitus	7.04e-06	0.000113	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC9A1—type 2 diabetes mellitus	7.01e-06	0.000112	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.97e-06	0.000111	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.94e-06	0.000111	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.94e-06	0.000111	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CETP—type 2 diabetes mellitus	6.93e-06	0.000111	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.92e-06	0.000111	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GCG—type 2 diabetes mellitus	6.92e-06	0.000111	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.91e-06	0.00011	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	6.83e-06	0.000109	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	6.83e-06	0.000109	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	6.83e-06	0.000109	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	6.83e-06	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.81e-06	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—C3—type 2 diabetes mellitus	6.66e-06	0.000106	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.61e-06	0.000106	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	6.57e-06	0.000105	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	6.55e-06	0.000105	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.5e-06	0.000104	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	6.5e-06	0.000104	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	6.47e-06	0.000104	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SREBF1—type 2 diabetes mellitus	6.44e-06	0.000103	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SNAP25—type 2 diabetes mellitus	6.44e-06	0.000103	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PSMD6—type 2 diabetes mellitus	6.44e-06	0.000103	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.44e-06	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.42e-06	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.42e-06	0.000103	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	6.38e-06	0.000102	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.36e-06	0.000102	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AGT—type 2 diabetes mellitus	6.32e-06	0.000101	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CTGF—type 2 diabetes mellitus	6.32e-06	0.000101	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMGCR—type 2 diabetes mellitus	6.27e-06	0.0001	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.24e-06	9.99e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.23e-06	9.97e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.22e-06	9.95e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.22e-06	9.94e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	6.2e-06	9.91e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.16e-06	9.86e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ADRA2A—type 2 diabetes mellitus	6.13e-06	9.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.11e-06	9.77e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	6.09e-06	9.74e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.09e-06	9.73e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.09e-06	9.73e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	6.03e-06	9.64e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.01e-06	9.61e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GNB3—type 2 diabetes mellitus	5.97e-06	9.55e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.97e-06	9.55e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HMOX1—type 2 diabetes mellitus	5.94e-06	9.5e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	5.92e-06	9.47e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.89e-06	9.43e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAT—type 2 diabetes mellitus	5.86e-06	9.38e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.84e-06	9.35e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.83e-06	9.32e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.83e-06	9.32e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	5.79e-06	9.27e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	5.77e-06	9.24e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOB—type 2 diabetes mellitus	5.69e-06	9.1e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	5.69e-06	9.09e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.68e-06	9.09e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.66e-06	9.06e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.64e-06	9.01e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	5.62e-06	8.99e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GCG—type 2 diabetes mellitus	5.59e-06	8.94e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.59e-06	8.94e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	5.57e-06	8.91e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	5.57e-06	8.91e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.57e-06	8.9e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.57e-06	8.9e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.55e-06	8.88e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	5.54e-06	8.85e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.48e-06	8.76e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	5.46e-06	8.74e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.46e-06	8.73e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	5.43e-06	8.69e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.43e-06	8.69e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	5.43e-06	8.68e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	5.43e-06	8.68e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	5.43e-06	8.68e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	5.39e-06	8.63e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	5.33e-06	8.52e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	5.32e-06	8.51e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	5.3e-06	8.48e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	5.3e-06	8.47e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	5.24e-06	8.38e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	5.23e-06	8.36e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.21e-06	8.33e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	5.16e-06	8.26e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.12e-06	8.19e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.11e-06	8.18e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.1e-06	8.15e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	5.06e-06	8.1e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	4.98e-06	7.96e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	4.96e-06	7.94e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	4.9e-06	7.84e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	4.89e-06	7.82e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.88e-06	7.81e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	4.87e-06	7.79e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	4.87e-06	7.79e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	4.87e-06	7.79e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.84e-06	7.74e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.81e-06	7.7e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	4.81e-06	7.7e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	4.8e-06	7.68e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.8e-06	7.67e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	4.79e-06	7.67e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.78e-06	7.64e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.74e-06	7.58e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.73e-06	7.57e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.73e-06	7.57e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	4.73e-06	7.56e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.71e-06	7.54e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.69e-06	7.5e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.67e-06	7.47e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	4.65e-06	7.43e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.64e-06	7.43e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.63e-06	7.41e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	4.59e-06	7.34e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.57e-06	7.32e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	4.57e-06	7.31e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.56e-06	7.29e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	4.55e-06	7.28e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	4.5e-06	7.2e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.5e-06	7.2e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	4.47e-06	7.14e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.45e-06	7.12e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.4e-06	7.04e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.4e-06	7.04e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	4.38e-06	7.01e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.37e-06	6.99e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	4.32e-06	6.91e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.29e-06	6.87e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	4.29e-06	6.86e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	4.28e-06	6.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.28e-06	6.84e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.27e-06	6.83e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	4.24e-06	6.78e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.22e-06	6.75e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.22e-06	6.75e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	4.17e-06	6.66e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.11e-06	6.58e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.1e-06	6.55e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.02e-06	6.44e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	3.97e-06	6.35e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.95e-06	6.31e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	3.93e-06	6.29e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	3.89e-06	6.22e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	3.89e-06	6.21e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.87e-06	6.19e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.75e-06	6e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.75e-06	6e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.74e-06	5.98e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.74e-06	5.98e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	3.72e-06	5.94e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.72e-06	5.94e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.69e-06	5.9e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.67e-06	5.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.67e-06	5.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.66e-06	5.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.66e-06	5.86e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.64e-06	5.82e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.64e-06	5.82e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	3.63e-06	5.81e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.62e-06	5.79e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.62e-06	5.79e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.57e-06	5.72e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	3.57e-06	5.71e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.47e-06	5.55e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.45e-06	5.52e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	3.41e-06	5.46e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.41e-06	5.46e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.4e-06	5.44e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.37e-06	5.4e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.31e-06	5.3e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.27e-06	5.22e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.24e-06	5.19e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.23e-06	5.17e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.2e-06	5.12e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.15e-06	5.03e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.14e-06	5.02e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	3.13e-06	5e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	3.12e-06	4.99e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.11e-06	4.97e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.08e-06	4.92e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.03e-06	4.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.02e-06	4.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.01e-06	4.81e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.98e-06	4.77e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.93e-06	4.68e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.88e-06	4.6e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.87e-06	4.6e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.83e-06	4.53e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.79e-06	4.46e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.78e-06	4.44e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.75e-06	4.4e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.75e-06	4.4e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.74e-06	4.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.74e-06	4.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.74e-06	4.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.58e-06	4.13e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.52e-06	4.03e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.42e-06	3.87e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.37e-06	3.79e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.35e-06	3.76e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.33e-06	3.72e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.31e-06	3.7e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.2e-06	3.52e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.18e-06	3.48e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.17e-06	3.48e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.13e-06	3.41e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.08e-06	3.33e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.08e-06	3.33e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.03e-06	3.25e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.98e-06	3.16e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.9e-06	3.04e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.81e-06	2.9e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.78e-06	2.84e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.71e-06	2.73e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.57e-06	2.51e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.37e-06	2.19e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.27e-06	2.02e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.26e-06	2.02e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.56e-07	1.53e-05	CbGpPWpGaD
